Skip to content

Author

Long Jing

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Gemtuzumab Ozogamicin-Containing Salvage Strategies as a Bridge to Second Allogeneic Hematopoietic Stem Cell Transplantation in Post-Transplant Relapsed AML.

GO-containing individualized salvage strategies were associated with manageable hepatic toxicity and feasible bridging to 2nd allo-HSCT, and achieving deep remission before transplantation may be critical for improving post-transplant outcomes.

Xiao-Hong Liu, Long Jing, Xing-Yu Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.